Results 191 to 200 of about 679,279 (310)

SARS-CoV-2 and Microbiologists

Medical Journal of Dr. D.Y. Patil Vidyapeeth, 2022
Nikunja Kumar Das, Rabindranath Misra, Rajashri Patil, Shahzad Mirza   +3 more
openaire   +2 more sources

Characterization and immunogenicity of nanoparticle vaccines displaying embecovirus spike proteins

Biotechnology Progress, EarlyView.
Virus‐like particle vaccines displaying spike proteins from OC43, HKU1 A, and HKU1 B were evaluated in mice for their ability to elicit antibodies against the spike proteins from OC43, HKU1 A, HKU1 B, and HKU1 C. Abstract Endemic human coronaviruses OC43 and HKU1 cause widespread respiratory infections and can be associated with severe illness in ...
Peter J. Halfmann, Augustine Duffy, Alex Wee, Noah Anderson, Jackson Terrell, Yoshihiro Kawaoka, Ravi S. Kane   +6 more
wiley   +1 more source

SARS-CoV-2 and reproductive system: a scientometric study. [PDF]

Front Reprod Health
Zhang L, Wang M, Zhang H, Mao G.
europepmc   +1 more source

Humoral epitope dominance and immune imprinting by SARS-CoV-1 and SARS-CoV-2 vaccines. [PDF]

Immunol Cell Biol
Burnett DL, Moxon A, Aggarwal A, Jackson KJ, Cotter C, Akerman A, Russell A, Kalman R, Langley D, Henry JY, Christ D, Bull RA, Brink R, Kelleher AD, Jäck HM, Turville S, Moss B, Goodnow CC.   +17 more
europepmc   +1 more source

Shedding Light on Synthetic Autocatalysis: From Conventional Closed‐Shell Chemistries to Overlooked Open‐Shell Occurrences

Chemistry – A European Journal, EarlyView.
Why add another catalyst when the product itself holds the power to catalyze its own formation? Autocatalysis in synthetic chemistry enhances reaction efficiency and uncovers novel catalytic behavior across both closed‐shell and open‐shell systems, expanding reactivity and enabling innovative design strategies.
Jaspreet Kaur, Joshua P. Barham
wiley   +1 more source

Bilateral subscapular hematoma following SARS‐CoV‐2 vaccination

Health Science Reports, 2023
Osamu Imataki, Makiko Uemura
doaj   +1 more source

SARS-CoV-2 Evolution and Its Implications for RT-PCR Diagnostic Performance. [PDF]

J Med Virol
Gupta S, Chaudhary A, Bhatnagar S.
europepmc   +1 more source

Membrane‐Permeable Nucleoside T‐1106 Diphosphate and Triphosphate Analogues as Antiviral Pronucleotides

Chemistry – A European Journal, EarlyView.
Favipiravir (T‐705) and the non‐fluorinated counterpart (T‐1106) are antiviral agents that inhibit the RNA‐dependent RNA polymerase (RdRp) of various RNA viruses. The antiviral efficacy of nucleoside analogues is strongly dependent on their intracellular activation by cellular kinases to produce their corresponding triphosphate metabolites (T‐705‐RTP ...
Chris Meier, Duan Li, Leentje Persoons, Graciela Andrei, Robert Snoeck, Dominique Schols, Lieve Naesens, Xiao Jia   +7 more
wiley   +1 more source

Functional and structural characterization of the SARS-CoV-2 spike N481K mutation. [PDF]

Arch Virol
Smatti MK, Al-Khatib H, Suleman M, Nizar M, Khalid HA, Ismail R, Nasrallah GK, Yassine HM.   +7 more
europepmc   +1 more source

Substrate‐Selective Inhibition of the SARS‐CoV‐2 Papain‐Like Protease: Inhibition of Hydrolysis of Human Over Viral Substrates

Chemistry – A European Journal, EarlyView.
The SARS‐CoV‐2 papain‐like protease (PLpro) is a medicinal chemistry target. Here we report mass spectrometry assays employing oligopeptide substrates based on the sequences of the viral polyproteins 1a/1ab and on an ISG15‐modified human protein, which enabled the identification of substrate‐selective PLpro inhibitors.
Sakshi Sharma, Peter A. C. Wing, Wojtek Treyde, Shyam Basak, Simeon D. Draganov, Taylah Andrews‐Clark, Eidarus Salah, Petra Lukacik, Claire Strain‐Damerell, Adán Pinto‐Fernández, Martin A. Walsh, Fernanda Duarte, Christopher J. Schofield, Lennart Brewitz   +13 more
wiley   +1 more source